These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23458879)

  • 1. Cell cycle arrest in Batten disease lymphoblast cells.
    Kang S; Kim JB; Heo TH; Kim SJ
    Gene; 2013 May; 519(2):245-50. PubMed ID: 23458879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells.
    Kang S; Heo TH; Kim SJ
    Gene; 2014 Apr; 539(2):181-5. PubMed ID: 24534465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.
    Rusyn E; Mousallem T; Persaud-Sawin DA; Miller S; Boustany RM
    Pediatr Res; 2008 Jun; 63(6):625-31. PubMed ID: 18317235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
    Puranam KL; Guo WX; Qian WH; Nikbakht K; Boustany RM
    Mol Genet Metab; 1999 Apr; 66(4):294-308. PubMed ID: 10191118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease).
    Warnock A; Tan L; Li C; An Haack K; Narayan SB; Bennett MJ
    Biochem Biophys Res Commun; 2013 Jul; 436(4):645-9. PubMed ID: 23769828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrates inhibit the apoptosis of Batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential.
    Hong M; Song KD; Lee HK; Yi S; Lee YS; Heo TH; Jun HS; Kim SJ
    In Vitro Cell Dev Biol Anim; 2016 Mar; 52(3):349-355. PubMed ID: 26659390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine normalizes the urea cycle and DNA repair in cells from patients with Batten disease.
    Kim JB; Lim N; Kim SJ; Heo TH
    Cell Biochem Funct; 2012 Dec; 30(8):677-82. PubMed ID: 22692827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
    Vitiello SP; Wolfe DM; Pearce DA
    Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
    Pearce DA; Ferea T; Nosel SA; Das B; Sherman F
    Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
    Gachet Y; Codlin S; Hyams JS; Mole SE
    J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].
    Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL
    Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.